Application of enoxaparin simultaneously with fibrinolysis in patients with acute myocardial infarction with ST-elevation
Author(s) -
N Despotović,
Goran Loncar,
Maja Nikolic-Despotovic,
Marjan Ilić,
Siniša Dimković,
Milutin Mirić
Publication year - 2009
Publication title -
medicinski pregled
Language(s) - English
Resource type - Journals
eISSN - 1820-7383
pISSN - 0025-8105
DOI - 10.2298/mpns0902013d
Subject(s) - medicine , streptokinase , heparin , myocardial infarction , enoxaparin sodium , fibrinolysis , cardiology , st elevation , fibrinolytic therapy , adverse effect , fibrinolytic agent , st segment , anesthesia , low molecular weight heparin , tissue plasminogen activator
Applied simultaneously with fibrinolytic therapy, low-molecular heparin enoxaparin is showing the potential of improving efficacy with rare adverse effects. Our objective was to investigate if enoxaparin with streptokinase (SK) in patients with acute myocardial infarction (AMI) had better effect than unfractioned heparin (UFH).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom